WallStreetZenWallStreetZen

NASDAQ: IMNM
Immunome Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for IMNM

Based on 2 analysts offering 12 month price targets for Immunome Inc.
Min Forecast
$33.00+131.42%
Avg Forecast
$34.00+138.43%
Max Forecast
$35.00+145.44%

Should I buy or sell IMNM stock?

Based on 2 analysts offering ratings for Immunome Inc.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their IMNM stock forecasts and price targets.

IMNM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-15
lockedlocked$00.00+00.00%2024-04-01

1 of 1

Forecast return on equity

Is IMNM forecast to generate an efficient return?

Forecast return on assets

Is IMNM forecast to generate an efficient return on assets?

IMNM revenue forecast

What is IMNM's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$16.0M+14.14%
Avg 2 year Forecast
$15.2M+8.75%
Avg 3 year Forecast
$53.1M+278.87%
IMNM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IMNM revenue growth forecast

How is IMNM forecast to perform vs Biotechnology companies and vs the US market?
Company
45.81%
Industry
37.04%
Market
9.92%
IMNM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IMNM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IMNM vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
IMNM$14.26$34.00+138.43%Strong Buy
SLN$21.62$57.25+164.80%Strong Buy
ALXO$16.87$18.25+8.18%Strong Buy
BCRX$4.16$11.00+164.42%Strong Buy
ARQT$8.59$13.50+57.16%Strong Buy
View Top Biotech Stocks

Immunome Stock Forecast FAQ

Is Immunome Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: IMNM) stock is to Strong Buy IMNM stock.

Out of 2 analysts, 1 (50%) are recommending IMNM as a Strong Buy, 1 (50%) are recommending IMNM as a Buy, 0 (0%) are recommending IMNM as a Hold, 0 (0%) are recommending IMNM as a Sell, and 0 (0%) are recommending IMNM as a Strong Sell.

If you're new to stock investing, here's how to buy Immunome stock.

What is IMNM's revenue growth forecast for 2024-2027?

(NASDAQ: IMNM) Immunome's forecast annual revenue growth rate of 45.81% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Immunome's revenue in 2024 is $14,018,000.On average, 1 Wall Street analysts forecast IMNM's revenue for 2024 to be $955,107,888, with the lowest IMNM revenue forecast at $955,107,888, and the highest IMNM revenue forecast at $955,107,888. On average, 2 Wall Street analysts forecast IMNM's revenue for 2026 to be $910,038,735, with the lowest IMNM revenue forecast at $232,210,605, and the highest IMNM revenue forecast at $1,587,866,864.

In 2027, IMNM is forecast to generate $3,170,361,246 in revenue, with the lowest revenue forecast at $3,170,361,246 and the highest revenue forecast at $3,170,361,246.

What is IMNM's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: IMNM) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is IMNM's Price Target?

According to 2 Wall Street analysts that have issued a 1 year IMNM price target, the average IMNM price target is $34.00, with the highest IMNM stock price forecast at $35.00 and the lowest IMNM stock price forecast at $33.00.

On average, Wall Street analysts predict that Immunome's share price could reach $34.00 by Apr 15, 2025. The average Immunome stock price prediction forecasts a potential upside of 138.43% from the current IMNM share price of $14.26.

What is IMNM's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: IMNM) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.